New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
10:11 EDTPWER, MGM, FET, CRL, RVBD, HP, XLNX, PNM, LUFK, CY, ATML, CLF, GILD, TFM, O, GNC, CRK, HAL, EFXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Atmel (ATML) upgraded to Buy from Hold at Needham... Best Buy (BBY) upgraded to Overweight from Equal Weight at Barclays... Charles River Labs (CRL) upgraded to Buy from Hold at Jefferies... Comstock Resources (CRK) upgraded to Outperform from Market Perform at BMO Capital... Cypress Semiconductor (CY) upgraded to Buy from Hold at Needham... Forum Energy (FET) upgraded to Outperform from Market Perform at FBR Capital... GNC Holdings (GNC) upgraded to Buy from Neutral at Goldman... Lufkin (LUFK) upgraded to Outperform from Market Perform at Wells Fargo... MGM Resorts (MGM) upgraded to Outperform from Sector Perform at RBC Capital... Realty Income (O) upgraded to Buy from Neutral at BofA/Merrill... PNM Resources (PNM) upgraded to Buy from Hold at Jefferies... Power-One (PWER) upgraded to Strong Buy from Outperform at Raymond James... The Fresh Market (TFM) upgraded to Buy from Neutral at Goldman... Xilinx (XLNX) upgraded to Buy from Neutral at BofA/Merrill... Equifax (EFX) upgraded to Overweight from Equal Weight at Evercore... Best Buy (BBY) upgraded to Buy from Hold at Stifel Nicolaus... Gilead (GILD) upgraded to Outperform from Neutral at Credit Suisse... Helmerich & Payne (HP) upgraded to Overweight from Equal Weight at Stephens... Halliburton (HAL) upgraded to Overweight from Equal Weight at Stephens... Cliffs Natural (CLF) upgraded to Overweight from Neutral at JPMorgan... Riverbed (RVBD) upgraded to Strong Buy from Buy at Needham.
News For ATML;CRL;CRK;CY;FET;GNC;LUFK;MGM;O;PNM;PWER;TFM;XLNX;EFX;GILD;HP;HAL;CLF;RVBD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
January 29, 2016
09:44 EDTGILDGilead slips as another drug enters Hepatitis C virus space
Shares of Gilead (GILD), a leader in the hepatitis C virus treatment space, are sliding this morning after one competitor's hep C drug was granted FDA approval and another's sales disappointed. Additionally, Gilead reported its own news, announcing a shakeup of the roles held by its top executives. MERCK APPROVAL: Merck (MRK) announced last night that the FDA has approved Zepatier for the treatment of adult patients with chronic hepatitis C virus, or HCV, genotype, or GT, 1 or GT4 infection. Merck has established a list price of $54,600 for a 12-week regimen of Zepatier, which the company said it believes to "be in the range of net prices for other commonly used HCV direct-acting antiviral regimens at 12 weeks of therapy." In contrast, a 12-week regimen of Gilead's Sovaldi is reported to be priced at $84,000. Merck added that it anticipates that this price, as well as its "strategy to seek broad coverage across commercial and public segments," will help broaden and accelerate patient access to treatment. ABBVIE RESULTS: Meanwhile, Gilead competitor AbbVie (ABBV) announced financial results for the fourth quarter this morning. AbbVie announced Q4 sales of Viekira Pak, its own hep C treatment, of $554M, including U.S. sales of $197M and international sales of $357M. Analysts expected AbbVie to report Q4 Viekira sales of $568.5M, according to a Bloomberg consensus estimate that factored in four forecasts. EXECUTIVE CHANGES: Additionally, Gilead announced this morning that current chairman and CEO John Martin will assume the role of executive chairman, effective March 10. John Milligan, currently president and COO, will be promoted to CEO and appointed to the company's board. PRICE ACTION: In morning trading, Gilead shares slipped 3.5% to $84.50, while AbbVie fell 2.4% to $54.53 and Merck (MRK) gained 1% to $49.75.
09:35 EDTGILDGilead falls, levels to watch
Subscribe for More Information
09:35 EDTMGMNevada reports Statewide December gaming win up 3.31% to $982.06M
The state also reports Las Vegas Strip December gaming win up 8.2% compared to last year at $600.75M compared to last year. Publicly traded companies in the space include Boyd Gaming (BYD), Caesars (CZR), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN) and Wynn Resorts (WYNN).
09:34 EDTGILDActive equity options trading on open: AMZN MSFT FB AAPL GILD GE
Subscribe for More Information
09:21 EDTGILDOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Gigamon (GIMO), up 17.7%... Fortinet (FTNT), up 10%... Flextronics (FLEX), up 10%... Skyworks (SWKS), up 5.7%... Seagate Technology (STX), up 4.9%.. Microsoft (MSFT), up 4.6%. ALSO HIGHER: Inovio Pharmaceuticals (INO), up 8.1% after CEO says Zika vaccine could enter human testing this year... J.C. Penney (JCP), up 2.1% after being upgraded to Neutral from Underperform at Credit Suisse... BRF S.A. (BRFS), up 3.1% after being upgraded to Buy from Hold at Deutsche Bank... Axiall (AXLL), up 83.4% after rejecting $20 per share acquisition proposal from Westlake Chemical (WLK)... Energous (WATT), up 12% after Bloomberg reported that Apple (AAPL) is working with partners in the U.S. and Asia to develop new wireless charging technology. DOWN AFTER EARNINGS: Amazon.com (AMZN), down 10.1%... Electronic Arts (EA), down 6.2%... AbbVie (ABBV), down 4%... American Airlines (AAL), down 1.3%. ALSO LOWER: Gilead Sciences (GILD), down 5.5% after CEO John Martin to assume role of executive chairman and COO John Milligan will be promoted to CEO.
08:21 EDTCYCypress Semiconductor downgraded to Neutral from Buy at Sterne Agee CRT
Subscribe for More Information
08:14 EDTGILDPiper Jaffray holds an analyst/industry conference call to discuss Gilead
Subscribe for More Information
08:01 EDTGILDGilead chairman, CEO John C. Martin to assume role of executive chairman
Subscribe for More Information
January 28, 2016
11:45 EDTCYCypress Semiconductor sees Q1 adjusted EPS 4c-8c, consensus 11c
Subscribe for More Information
11:39 EDTHPHelmerich & Payne says Permian driving better U.S. well performance
Subscribe for More Information
11:28 EDTHPHelmerich & Payne says has term contracts for 87 rigs in Q2
Subscribe for More Information
11:11 EDTHPHelmerich & Payne: Tone for 2016 has shifted to 'lower for longer' oil prices
Subscribe for More Information
10:04 EDTHALOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Amdocs (DOX) upgraded to Buy from Neutral at BofA/Merrill... Cheesecake Factory (CAKE) upgraded to Overweight from Equal Weight at Stephens... Chemical Financial (CHFC) upgraded to Buy from Hold at Sandler O'Neill... Cimarex Energy (XEC) upgraded to Buy from Hold at Wunderlich... Cirrus Logic (CRUS) upgraded to Outperform from Perform at Oppenheimer... Citrix (CTXS) upgraded on Q4 results, valuation at JMP Securities... Comerica (CMA) upgraded to Market Perform from Underperform at BMO Capital... Community Health (CYH) upgraded to Market Perform from Underperform at Raymond James... Denny's (DENN) upgraded to Overweight from Equal Weight at Stephens... Dolby (DLB) upgraded to Buy from Neutral at Dougherty... EMC (EMC) upgraded to Buy from Neutral at Mizuho... Halliburton (HAL) upgraded to Buy from Accumulate at KLR Group... Hanmi Financial (HAFC) upgraded to Strong Buy from Outperform at Raymond James... Hawaiian Holdings (HA) upgraded to Neutral at BofA/Merrill... Hologic (HOLX) upgraded to Buy from Hold at Needham... Kinder Morgan (KMI) upgraded at Stifel... MGM China (MCHVF) upgraded to Overweight from Neutral at JPMorgan... Nimble Storage (NMBL) upgraded to Buy from Hold at Maxim... Patterson Companies (PDCO) upgraded to Buy from Neutral at UBS... PayPal (PYPL) upgraded to Outperform on core market share gains at Wedbush... Prosperity Bancshares (PB) upgraded to Buy from Neutral at DA Davidson... RPC, Inc. (RES) upgraded to Overweight from Equal Weight at Morgan Stanley... Rowan Companies (RDC) upgraded to Equal Weight from Underweight at Morgan Stanley... SanDisk (SNDK) upgraded to Buy from Neutral at Mizuho... Stillwater Mining (SWC) upgraded to Outperform from Market Perform at FBR Capital... Vantiv (VNTV) upgraded to Positive from Neutral at Susquehanna... Wilshire Bancorp (WIBC) upgraded to Outperform from Market Perform at Raymond James.
08:08 EDTCYCypress Semiconductor sees Q1 EPS 4c-8c, consensus 11c
Sees Q1 non-GAAP net sales $410M-$440M, consensus $420.4M. Sees Q1 gross margin of 36%.
08:07 EDTCYCypress Semiconductor reports Q4 EPS 13c, consensus 13c
Reports Q4 revenue $456.4M, consensus $445.22M.
08:06 EDTHALBaker Hughes says 'fully dedicated' to closing merger as early as possible
Subscribe for More Information
06:18 EDTHPHelmerich & Payne sees Q2 US land segment revenue days to decrease 20%
Subscribe for More Information
06:17 EDTHPHelmerich & Payne reports Q1 land operations operating income $56M
Subscribe for More Information
06:16 EDTHPHelmerich & Payne reports Q1 adjusted 5c, consensus (7c)
Reports Q1 revenue $487.85M, consensus $458.65M.
06:07 EDTHALHalliburton upgraded to Buy from Accumulate at KLR Group
KLR Group analyst Darren Gacicia upgraded Halliburton (HAL) to Buy saying the risk/reward is favorable at current share levels. North America should be the first region to increase oil production activity in a recovery, and Halliburton has high exposure, Gacicia tells investors in a research note. Further, investor concerns related to the Baker Hughes (BHI) merger may present a positive catalyst for the shares whether the merger is completed or terminated, the analyst contends. He believes both companies remain motivated to complete the deal. Gacicia keeps a $44 price target for Halliburton shares. The oil services company closed yesterday up 12c to $29.06.
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use